Myocardial Concentrations of Inositol and cAMP in Intact Failured Rats

[1]  E. Woodcock,et al.  Ins(1,4,5)P3 and cardiac dysfunction. , 1998, Cardiovascular research.

[2]  K. Werdan,et al.  A post-receptor defect of adenylyl cyclase in severely failing myocardium from children with congenital heart disease. , 1997, European journal of pharmacology.

[3]  K. Hwang,et al.  α 1-Adrenergic receptor coupling with G(h) in the failing human heart , 1996 .

[4]  G. Licata,et al.  A new method to measure cardiac inositol levels in intact animals. , 1996, Journal of pharmacological and toxicological methods.

[5]  K. Hwang,et al.  Alpha 1-adrenergic receptor coupling with Gh in the failing human heart. , 1996, Circulation.

[6]  E. Lakatta,et al.  Response of Failing Canine and Human Heart Cells to β2-Adrenergic Stimulation , 1995 .

[7]  G. Licata,et al.  Effect of captopril on lymphocytic beta-adrenergic receptors in normal and hypoxic conditions. , 1994, International journal of cardiology.

[8]  M. Steinfath,et al.  Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. , 1994, Journal of molecular and cellular cardiology.

[9]  K. Bezstarosti,et al.  Distinct alpha 1-adrenergic agonist- and endothelin-1-evoked phosphoinositide cycle responses in cultured neonatal rat cardiomyocytes. , 1994, Biochemical and biophysical research communications.

[10]  J. Pepper,et al.  Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle. , 1993, Circulation.

[11]  Morgan He Cellular aspects of cardiac failure. , 1993 .

[12]  E. Woodcock,et al.  Inositol phosphates in rat atria and the importance of the extraction procedure. , 1993, Journal of molecular and cellular cardiology.

[13]  H. E. Morgan Cellular aspects of cardiac failure. , 1993, Circulation.

[14]  E. Woodcock,et al.  Different pathways of inositol phosphate metabolism in intact neonatal rat hearts and isolated cardiomyocytes. , 1992, The Biochemical journal.

[15]  A. Kuznetsov,et al.  Phosphocreatine pathway for energy transport: ADP diffusion and cardiomyopathy. , 1991, The American journal of physiology.

[16]  A. Lochner,et al.  Increased myocardial inositol trisphosphate levels during alpha 1-adrenergic stimulation and reperfusion of ischaemic rat heart. , 1991, Journal of molecular and cellular cardiology.

[17]  K. Baker,et al.  Cardiac Hypertrophy: Mechanical, Neural, and Endocrine Dependence , 1991 .

[18]  C. Ragan,et al.  Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. , 1991, Trends in pharmacological sciences.

[19]  B. Swynghedauw Remodeling of the heart in chronic pressure overload. , 1991, Basic research in cardiology.

[20]  P. Corr,et al.  Enhanced inositol trisphosphate response to alpha 1-adrenergic stimulation in cardiac myocytes exposed to hypoxia. , 1989, The Journal of clinical investigation.

[21]  K. Werdan,et al.  Homologous vs. heterologous desensitization of the adenylate cyclase system in heart cells. , 1988, European journal of pharmacology.

[22]  W. Baumgartner,et al.  Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. , 1988, The Journal of clinical investigation.

[23]  J. Scholz,et al.  Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart. , 1988, The Journal of pharmacology and experimental therapeutics.

[24]  E. Woodcock,et al.  Stimulation of Phosphatidylinositol Metabolism in the Isolated, Perfused Rat Heart , 1987, Circulation research.

[25]  H. Wikiel,et al.  Effects of Cerebral Ischemia on [3H]Inositol Lipids and [3H]Inositol Phosphates of Gerbil Brain and Subcellular Fractions , 1987, Journal of neurochemistry.

[26]  F. Schoen,et al.  Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. , 1987, Circulation.

[27]  M. Berridge,et al.  Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. , 1983, The Biochemical journal.

[28]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[29]  J. Whelan,et al.  A simple direct assay for cyclic AMP in plasma and other biological samples using an improved competitive protein binding technique. , 1974, Clinica chimica acta; international journal of clinical chemistry.

[30]  Fulton Rm,et al.  VENTRICULAR WEIGHT IN CARDIAC HYPERTROPHY , 1952 .